What's breaking now, across thousands of outlets.
The FDA appears likely to hold an advisory committee for UniQure’s closely watched Huntington’s disease gene therapy. Elsewhere, a biotech’s share price was cut in half following a regulatory setback.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Diabetes-related foot ulcers are often associated with numbness in the feet. According to patients, the fact that these ulcers can also cause severe and unpredictable pain does not receive sufficient…
[Daily Trust] Former Kano Pillars Technical Adviser, Coach Ibrahim Musa, has announced that after struggling with cataracts for 10 years, he has completely lost his sight.
Die Mainzer stecken viel Geld in die Forschung, hoffen auf Zulassungen in der Onkologie. Unter dem dritten Quartal steht nun ein Plus. Der Abschied des Gründer-Ehepaares wirft seine Schatten voraus.
The health policy think tank urged seniors to shop carefully for prescription drug coverage during Medicare open enrollment, given skyrocketing premiums and wide variance in costs between plans.
[Capital FM] Nairobi -- Kenya is set to expand access to solar electricity in remote rural communities following a new agreement with China targeting schools, health facilities and water supply…
A child in rural northern New York has died after contracting measles, marking the state's first death from the disease in 30 years.
